International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 199-206 doi: 10.5281/zenodo.16416816
Original Article
Maternal and Neonatal Outcomes in Multifetal Pregnancy: An Observational Study at a Tertiary Care Centre in Assam, India
Published
July 21, 2025
Abstract

Background: Multifetal gestation is associated with increased maternal and neonatal complications. With the rise of assisted reproductive technologies (ART), the incidence of such pregnancies has increased.
Objective: To evaluate the maternal and neonatal outcomes in multifetal pregnancies and assess the associated complications and mortality at a tertiary care center in Jorhat, Assam.
Methods: A prospective observational study was conducted from March 2023 to February 2024 at Jorhat Medical College and Hospital. Fifty women with multifetal gestation ≥28 weeks were enrolled. Data on demographic factors, antenatal care, complications, mode of delivery, and neonatal outcomes were collected and analyzed.
Results: Out of 4744 births, 50 were multifetal gestations (49 twins, 1 triplet), giving an incidence of 1.05%. Majority (62%) were aged 21–29 years and unbooked (80%). Primigravidas accounted for 62%. ART was the cause in 12%, and 58% delivered between 29–36 weeks. Most were dichorionic-diamniotic (64%). Maternal complications included anemia (62%), preterm labor (58%), hypertensive disorders (14%), PPROM (14%), PROM (12%), APH (6%), and PPH (22%). Cesarean section rate was 62%, most commonly for malpresentation. Perinatal mortality was 8.1%. There was no maternal mortality.
Conclusion: Multifetal pregnancies are associated with increased maternal and neonatal morbidity. Early diagnosis, regular antenatal care, and adequate neonatal support can significantly improve outcomes.

Keywords: Multifetal pregnancy, maternal outcome, neonatal outcome, twin pregnancy, high-risk pregnancy

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1958 Views
130 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved